Area of research
Neurology · Epidemiology
Research interest
Research interests include Intracerebral and Subarachnoid Hemorrhage Research, Vascular Malformations Diagnosis and Treatment, Intracranial Aneurysms: Treatment and Complications, and Acute Ischemic Stroke Management.
Transcriptomic signatures of individual cell types in cerebral cavernous malformation
Plasma metabolites with mechanistic and clinical links to the neurovascular disease cavernous angioma
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling
Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease
Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage
Perfusion and Permeability<scp>MRI</scp>Predicts Future Cavernous Angioma Hemorrhage and Growth
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials
Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH)
Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure
Biomarkers of cavernous angioma with symptomatic hemorrhage
Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH)
The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial
CSF inflammatory response after intraventricular hemorrhage
Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage
Bleeding and Infection With External Ventricular Drainage
Spontaneous Intracerebral and Intraventricular Hemorrhage